Unknown

Dataset Information

0

Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump.


ABSTRACT: Automated insulin management features of the MiniMed® 640G sensor-augmented pump system include suspension in response to predicted low sensor glucose (SG) values ("suspend before low"), suspension in response to existing low SG values ("suspend on low"), and automatic restarting of basal insulin delivery upon SG recovery. The effectiveness of these features was evaluated using CareLink® software data.Anonymized data from MiniMed 640G system users (n?=?4818), MiniMed 530G system users (n?=?39,219), and MiniMed Paradigm® Veo™ system users (n?=?43,193) who voluntarily uploaded pump and sensor data were retrospectively analyzed. Comparisons were made between days in which system features were enabled at any time and those in which they were not. Comparisons were also made between pump suspension events for which insulin delivery was automatically or manually resumed and between glycemic parameters of users who switched from the MiniMed Paradigm Veo system to the MiniMed 640G system.Days in which the MiniMed 640G "suspend before low" feature was enabled had lower percentages of SG readings ?70?mg/dL (3.9?mmol/L) or ?240?mg/dL (13.3?mmol/L) than days when it was not enabled (P?

SUBMITTER: Zhong A 

PROVIDER: S-EPMC5111481 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effectiveness of Automated Insulin Management Features of the MiniMed<sup>®</sup> 640G Sensor-Augmented Insulin Pump.

Zhong Alex A   Choudhary Pratik P   McMahon Chantal C   Agrawal Pratik P   Welsh John B JB   Cordero Toni L TL   Kaufman Francine R FR  

Diabetes technology & therapeutics 20160927 10


<h4>Background</h4>Automated insulin management features of the MiniMed<sup>®</sup> 640G sensor-augmented pump system include suspension in response to predicted low sensor glucose (SG) values ("suspend before low"), suspension in response to existing low SG values ("suspend on low"), and automatic restarting of basal insulin delivery upon SG recovery. The effectiveness of these features was evaluated using CareLink<sup>®</sup> software data.<h4>Methods</h4>Anonymized data from MiniMed 640G syst  ...[more]

Similar Datasets

| S-EPMC3177536 | biostudies-literature
| S-EPMC7788343 | biostudies-literature
| S-EPMC10755613 | biostudies-literature
| S-EPMC7906861 | biostudies-literature
| S-EPMC3696941 | biostudies-literature
| S-EPMC5638091 | biostudies-literature
| S-EPMC3198292 | biostudies-literature
| S-EPMC9294564 | biostudies-literature